336 related articles for article (PubMed ID: 18528864)
61. Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol.
Welshons WV; Murphy CS; Koch R; Calaf G; Jordan VC
Breast Cancer Res Treat; 1987 Nov; 10(2):169-75. PubMed ID: 3427225
[TBL] [Abstract][Full Text] [Related]
62. Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies).
Saarinen NM; Wärri A; Mäkelä SI; Eckerman C; Reunanen M; Ahotupa M; Salmi SM; Franke AA; Kangas L; Santti R
Nutr Cancer; 2000; 36(2):207-16. PubMed ID: 10890032
[TBL] [Abstract][Full Text] [Related]
63. Development and therapeutic options for the treatment of raloxifene-stimulated breast cancer in athymic mice.
O'Regan RM; Osipo C; Ariazi E; Lee ES; Meeke K; Morris C; Bertucci A; Sarker MA; Grigg R; Jordan VC
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2255-63. PubMed ID: 16609042
[TBL] [Abstract][Full Text] [Related]
64. Effects of non-digestible carbohydrates on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice.
Kondegowda NG; Meaney MP; Baker C; Ju YH
Nutr Cancer; 2011; 63(1):55-64. PubMed ID: 21170812
[TBL] [Abstract][Full Text] [Related]
65. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
Ting AY; Kimler BF; Fabian CJ; Petroff BK
Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
[TBL] [Abstract][Full Text] [Related]
66. Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats.
Luo S; Stojanovic M; Labrie C; Labrie F
Int J Cancer; 1997 Nov; 73(4):580-6. PubMed ID: 9389575
[TBL] [Abstract][Full Text] [Related]
67. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
Tsai TL; Katzenellenbogen BS
Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
[TBL] [Abstract][Full Text] [Related]
68. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
69. 7,8-Dihydroxycoumarin exerts antitumor potential on DMBA-induced mammary carcinogenesis by inhibiting ERα, PR, EGFR, and IGF1R: involvement of MAPK1/2-JNK1/2-Akt pathway.
Kumar A; Sunita P; Jha S; Pattanayak SP
J Physiol Biochem; 2018 May; 74(2):223-234. PubMed ID: 29435821
[TBL] [Abstract][Full Text] [Related]
70. Comparative abilities of athymic nude mice and severe combined immune deficient (SCID) mice to accept transplants of induced rat mammary carcinomas: enhanced transplantation efficiency of those rat mammary carcinomas that have elevated expression of neu oncogene.
Oakley CS; Welsch MA; Zhai YF; Chang CC; Gould MN; Welsch CW
Int J Cancer; 1993 Apr; 53(6):1002-7. PubMed ID: 8097186
[TBL] [Abstract][Full Text] [Related]
71. Effects of flaxseed lignan and oil on bone health of breast-tumor-bearing mice treated with or without tamoxifen.
Chen J; Saggar JK; Ward WE; Thompson LU
J Toxicol Environ Health A; 2011; 74(12):757-68. PubMed ID: 21541878
[TBL] [Abstract][Full Text] [Related]
72. Obesity and the associated mediators leptin, estrogen and IGF-I enhance the cell proliferation and early tumorigenesis of breast cancer cells.
Lautenbach A; Budde A; Wrann CD; Teichmann B; Vieten G; Karl T; Nave H
Nutr Cancer; 2009; 61(4):484-91. PubMed ID: 19838920
[TBL] [Abstract][Full Text] [Related]
73. Role of 5-lipoxygenase in resveratrol mediated suppression of 7,12-dimethylbenz(α)anthracene-induced mammary carcinogenesis in rats.
Chatterjee M; Das S; Janarthan M; Ramachandran HK; Chatterjee M
Eur J Pharmacol; 2011 Oct; 668(1-2):99-106. PubMed ID: 21749863
[TBL] [Abstract][Full Text] [Related]
74. In vitro and in vivo antitumorigenic activity of a mixture of lysine, proline, ascorbic acid, and green tea extract on human breast cancer lines MDA-MB-231 and MCF-7.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Med Oncol; 2005; 22(2):129-38. PubMed ID: 15965275
[TBL] [Abstract][Full Text] [Related]
75. Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis.
Thompson LU; Rickard SE; Orcheson LJ; Seidl MM
Carcinogenesis; 1996 Jun; 17(6):1373-6. PubMed ID: 8681458
[TBL] [Abstract][Full Text] [Related]
76. Antiproliferative effect of peripheral benzodiazepine receptor antagonist PK11195 in rat mammary tumor cells.
Mukhopadhyay S; Guillory B; Mukherjee S; Das SK
Mol Cell Biochem; 2010 Jul; 340(1-2):203-13. PubMed ID: 20204676
[TBL] [Abstract][Full Text] [Related]
77. Cetirizine and thalidomide synergistically inhibit mammary tumorigenesis and angiogenesis in 7,12-dimethylbenz(a)anthracene-treated rats.
Ionov ID; Gorev NP; Roslavtseva LA; Frenkel DD
Anticancer Drugs; 2018 Nov; 29(10):956-964. PubMed ID: 30134286
[TBL] [Abstract][Full Text] [Related]
78. A rat cell line derived from DMBA-induced mammary carcinoma.
Chow LW; Cheung MN; Loo WT; Guan XY
Life Sci; 2003 May; 73(1):27-40. PubMed ID: 12726884
[TBL] [Abstract][Full Text] [Related]
79. Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol.
Milder IE; Arts IC; van de Putte B; Venema DP; Hollman PC
Br J Nutr; 2005 Mar; 93(3):393-402. PubMed ID: 15877880
[TBL] [Abstract][Full Text] [Related]
80. Enterolactone has stronger effects than enterodiol on ovarian cancer.
Liu H; Liu J; Wang S; Zeng Z; Li T; Liu Y; Mastriani E; Li QH; Bao HX; Zhou YJ; Wang X; Hu S; Gao S; Qi Y; Shen Z; Wang H; Yu M; Gao T; Johnston RN; Liu SL
J Ovarian Res; 2017 Jul; 10(1):49. PubMed ID: 28738876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
